Online Only Articles

Outcomes of patients with relapsed aggressive adult T-cell leukemia-lymphoma: clinical effectiveness of anti-CCR4 antibody and allogeneic hematopoietic stem cell transplantation

Department of Hematology, Osaka International Cancer Institute, Tokyo, Japan;Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
Department of Hematology, Imamura General Hospital, Kagoshima, Japan
Department of Hematology, Kumamoto University Hospital, Okinawa, Japan
Department of Hematology, Heart-Life Hospital, Okinawa, Japan
Department of Hematology, National Hospital Organization Kagoshima Medical Center, Nagasaki, Japan
Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan
Department of Hematology, Sasebo City General Hospital, Nagasaki, Japan
Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
Department of Hematology, Respiratory Medicine and Oncology, Saga University School of Medicine, Fukuoka, Japan
Department of Hematology, National Hospital Organization Nagasaki Medical Center, Fukuoka, Japan
Department of Hematology and Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan
Division of Biostatistics, Tohoku University Graduate School of Medicine, Sendai, Japan
Department of Hematology, Osaka International Cancer Institute, Tokyo, Japan
Vol. 103 No. 5 (2018): May, 2018 https://doi.org/10.3324/haematol.2017.184564